Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
Cart
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Home
Journals
Biometrical Letters
Volume 53 (2016): Issue 2 (December 2016)
Open Access
A comparison between the continual reassessment method and
D
-optimum design for dose finding in phase I clinical trials
M. Iftakhar Alam
M. Iftakhar Alam
| Dec 10, 2016
Biometrical Letters
Volume 53 (2016): Issue 2 (December 2016)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Dec 10, 2016
Page range:
69 - 82
DOI:
https://doi.org/10.1515/bile-2016-0006
Keywords
Dose finding studies
,
Phase I trial
,
Maximum tolerated dose
,
Continual reassessment method
,
-optimum design
© 2016 M. Iftakhar Alam, published by De Gruyter Open
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
M. Iftakhar Alam
Institute of Statistical Research and Training, University of Dhaka, Dhaka-1000, Bangladesh